Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04658979
Other study ID # 21983
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2020
Est. completion date January 2022

Study information

Verified date December 2020
Source Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Contact Didier Saey, Ph.D
Phone 418-656-8711
Email didier.saey@criucpq.ulaval.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pulmonary disease like interstitial lung disease (ILD) and chronic obstructive lung disease (COPD) are a significant health problem in Canada and around the world. In addition to the respiratory impairment resulting to a progressive dyspnea, these diseases are also characterized by a decrease in exercise tolerance and muscle dysfunction which affect the patient's quality of life. Respiratory rehabilitation is the cornerstone of the management of chronic disease and it includes a set of personalized care mainly delivered in person by a transdisciplinary team and with the objectives of reducing the symptoms felt by the participants and improving their physical and psychosocial condition. The current containment due to the COVID-19 pandemic increase the sedentary behavior of patients and prevents the holding of any respiratory rehabilitation activity. In this context, tele-rehabilitation appears to be a particularly well-suited solution because it would make it possible to offer a respiratory rehabilitation in a safe and effective manner while minimizing contact with the participants. Although some studies support the feasibility of this intervention, more data is needed to validate its routine clinical application. The main objective of this study is to verify the safety and the feasibility of delivering pulmonary rehabilitation treatments entirely at home via a telerehabilitation patform developed at the Institut universitraire de cardiologie et de pneumologie de Québec (IUCPQ), and document its effectiveness in people with chronic respiratory disease. The secondary objectives will be: 1) to explore the effects of a telerehabilitation programm on exercise tolerance, muscle function, functional capacity and quality of life, and 2) to assess the satisfaction of participants and health care providers with telerehabilitation.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date January 2022
Est. primary completion date March 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - The patient already participate to the telerehabilitation program in the PPMC at IUCPQ

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pulmonary tele-rehabilitation
All the participant will by include in a tele-rehabilitation program who will be based on an 12-week intervention including therapeutic education and self-management sessions and training sessions, delivered through a videoconferencing application. All interventions will be under the supervision of a rehabilitation professional from the Pavillon de prévention des maladies cardiovasculaire (PPMC) and modeled according to the recommendations of the ATS/ERS.

Locations

Country Name City State
Canada Institut universitaire de cardiologie et de pneumologie de Québec Québec Quebec

Sponsors (2)

Lead Sponsor Collaborator
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec Fondation IUCPQ

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasability - Patients´ satisfaction with the program between baseline and the up to 12 weeks follow-up Patient's satisfaction will be evaluated by a questionnaire including 7 questions on his feeling of competence with regard to the program, based on an 8-point Likert scale (0 to 7). 12 weeks
Primary Feasability - Health care professionals' receptivity Health care professionals' receptivity towards the tele-rehabilitation will be assess by 18 questions based on an 6-point scale (0 to 5). 12 weeks
Primary Feasibility - Patients' satisfaction with the health care received Patient's satisfaction will be evaluated by a questionnaire including 23 questions based on a 4-point scale (1 to 4). 12 weeks
Secondary Quality of life by questionnaire For the COPD participants the quality of live will be evaluated with the COPD Assessment test (CAT) and fort he ILD participants with the Kings' Brief Interstitial Lung Disease (K-BLID) questionnaire.
CAT = K-BLID = 15 questions rate between 1 to 7 (maximal score = 105 = better quality of life; minimal score = 15 = worse quality of life)
12 weeks
Secondary Dyspnea level The dyspnea level will be evaluated with the MRC questionnaire = 4 questions If the patient answer yes to the first question he continue to the next question, if he answer no the questionnaire is finish. The further he goes in the questionnaire, worse the breathlessness score is. 12 weeks
Secondary Exercise capacity The exercise capacity will be evaluated by the 6-minutes stepper test before and after the program, the result will be the number of cycle complet 12 weeks
Secondary Exercise capacity The exercise capacity will be evaluated by the 1-minute sit to stand test before and after the program, the result will be the number of complet sit to stand. 12 weeks
Secondary Functionnal capacity The functional capacity will be evaluated by the Short Physical Performance Battery test (SPPB) test before and after the program, the result will be the total on 12. 12 weeks
Secondary Functionnal capacity The functional capacity will be evaluated by the hand grip test before and after the program and measured in kilograms. 12 weeks
Secondary Functionnal capacity The functional capacity will be evaluated by the maximum voluntary contraction force of the quadriceps before and after the program. 12 weeks
Secondary Anxiety The anxiety will be assess by the Hospital Anxiety and Depression scale (HAD). Total of 14 questions (maximal score = 42 = worse; minimal score = 0= better) where 7 questions is for the anxiety score(maximal score = 21 = worse; minimal score = 0= better) 12 weeks
Secondary Depression The depression will by assess by Hospital Anxiety and Depression scale.14 questions (maximal score = 42 = worse; minimal score = 0= better) where 7 questions is for the depression score (maximal score = 21 = worse; minimal score = 0= better) 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05596877 - Music Therapy in Pulmonary Rehabilitation N/A
Not yet recruiting NCT05087199 - COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
Recruiting NCT04380558 - Prevalence and Consequences of Urinary Incontinence in People With Chronic Pulmonary Diseases Referred for Pulmonary Rehabilitation
Not yet recruiting NCT06315374 - 3D-Printed Aerosolized Medication Delivery Assist Device in Patients With Chronic Respiratory Diseases N/A
Completed NCT01032395 - Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus Phase 3
Completed NCT03847753 - Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
Terminated NCT04828837 - Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects N/A
Completed NCT05760352 - Comparison of Multiple Exercise Trainings in Chronic Respiratory Disease N/A